Evidence map›Paper›PMID 40510837›Full record

ArticleMaterials today. Bio2025

Engineering 3D-BMSC exosome-based hydrogels that collaboratively regulate bone microenvironment and promote osteogenesis for enhanced cell-free bone regeneration.

Kai Xiang, Muwei Hao, Zheng Zhang, Keyi Zhang, Han Sun, Lei Zhang

Abstract read
In one paragraph

Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kai XiangSchool of Pharmacy, Wannan Medical College, Wuhu, 241002, China.
Muwei HaoSchool of Pharmacy, Wannan Medical College, Wuhu, 241002, China.
Zheng ZhangSchool of Pharmacy, Wannan Medical College, Wuhu, 241002, China.
Keyi ZhangSchool of Pharmacy, Wannan Medical College, Wuhu, 241002, China.
Han SunArticular Orthopaedics, The Third Affiliated Hospital of Soochow University, 185 Juqian Street, Changzhou, 213003, Jiangsu, China.
Lei ZhangSchool of Pharmacy, Wannan Medical College, Wuhu, 241002, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Large bone defects are a significant clinical challenge due to their frequent failure to heal spontaneously. Recently, BMSC-derived exosomes (Exo) based cell-free bone regeneration offer several distinct advantages over BMSCs themselves in the repair of damaged tissue, including enhanced repair ability and superior biocompatibility, which can be further augmented under 3D-cultured conditions. However, their therapeutic efficacy for bone regeneration is significantly constrained by hypoxic bone microenvironment and short retention time in bone defect region. Thus, judiciously regulating bone microenvironment and extending retention time are crucial for bone regeneration. Herein, we developed Superparamagnetic Iron Oxide Nanoparticles (SPION) -modified 3D-cultured Exo, termed as 3D-SExo, to enhance Reactive Oxygen Species (ROS) scavenging and promote bone regeneration in response to the needs of bone defect. After entrapment in bone-targeting peptide-modified GelMA (Gel-DSS6), the composite hydrogel (3D-SExo/DGel) was obtained, which can prolong the retention of exosomes, and thereby enhancing bone repair ability. In addition, miR-122-5p, detected via microRNA (miRNA) array from 3D-cultured Exo, were observed to promote osteogenesis by activating Wnt/β-catenin pathway, which was further verified by miRNA transfection. Through the

Indexed as

Bone-targeted hydrogelsCollaboratively promote osteogenesisEngineered 3D-BMSC ExosomeEnhanced cell‐free bone regenerationReactive oxygen speciesWnt/β-catenin pathway

Identifiers

PMID40510837
PMCPMC12159235

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.